These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 3305833

  • 1. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation.
    Deeb GM, Kolff J, McClurken JB, Dunn J, Balsara R, Ochs R, Badellino M, Hollander T, Eldridge C, Clancey M.
    J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833
    [Abstract] [Full Text] [Related]

  • 2. Acute renal failure after heart transplantation and cyclosporine therapy.
    McGiffin DC, Kirklin JK, Naftel DC.
    J Heart Transplant; 1985; 4(4):396-9. PubMed ID: 3916513
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of minimal dosage cyclosporine in limiting toxicity and rejection.
    Spratt P, Esmore D, Baron D, Shanahan MX, Farnsworth AE, Chang VP.
    J Heart Transplant; 1986; 5(1):8-12. PubMed ID: 3302158
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial.
    Esmore DS, Spratt PM, Keogh AM, Chang VP.
    J Heart Transplant; 1989; 8(3):194-9. PubMed ID: 2661768
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heart transplantation in females.
    Esmore D, Keogh A, Spratt P, Jones B, Chang V.
    J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
    [Abstract] [Full Text] [Related]

  • 9. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR, Hastillo A, Goldman MH, Szentpetery S, Wolfgang TC, Mohanakumar T, Katz MR, Rider S, Hanrahan J, Lower RR.
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reversal of cardiac transplant rejection without massive immunosuppression.
    Michler RE, Smith CR, Drusin RE, Reison DS, Hickey TJ, Lamb J, Reemtsma K, Rose EA.
    Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
    [Abstract] [Full Text] [Related]

  • 14. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM.
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Powerful but limited immunosuppression for cardiac transplantation with cyclosporins and low-dose steroid.
    Griffith BP, Hardesty RL, Bahnson HT.
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):35-42. PubMed ID: 6361393
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Jan; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 20. Selective use of OKT3 in heart transplantation with the use of risk factor analysis.
    Macris MP, Van Buren CT, Sweeney MS, Frazier OH, Duncan JM.
    J Heart Transplant; 1989 Jan; 8(4):296-302. PubMed ID: 2504896
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.